PMID: 11899261Mar 20, 2002Paper

Progress in gene delivery by cationic lipids: guanidinium-cholesterol-based systems as an example

Current Drug Targets
Abderrahim AissaouiP Lehn

Abstract

Artificial self-assembling systems are currently widely investigated as an alternative approach to recombinant viruses for gene transfection in vitro and in vivo. Cationic lipids are particularly attractive, as a great variety of well-characterized reagents can be synthesized from there. Over the last few years, numerous cationic lipid systems have been developed and shown to be efficient for in vitro transfection. However, although some promising results have been reported in the in vivo setting (even in clinical gene therapy trials in man), the in vivo use of cationic lipid-based systems is still problematic, especially when considering the systemic route of administration. Herein, we summarize our own research on a particular class of cationic lipids, cholesterol derivatives characterized by polar headgroups with guanidinium functions, in order to illustrate the basic principles of and the positive results already obtained by cationic lipid-mediated gene delivery as well as the remaining problems that need to be urgently resolved, particularly as regards the systemic administration. In this forward-looking review, we also discuss the present efforts to develop modular systems for improved in vivo transfection. Indeed, lipid-...Continue Reading

Citations

Sep 19, 2009·Genetica·Romain LabasBruno Pitard
Mar 25, 2011·Journal of Pharmacy & Bioallied Sciences·Sarantis Giatrellis, George Nounesis
Nov 23, 2011·Expert Opinion on Drug Delivery·Yinan ZhaoShufen Zhang
Apr 3, 2012·Advanced Drug Delivery Reviews·Jongdoo Lim, Eric E Simanek
Oct 8, 2011·International Journal of Pharmaceutics·Mamta KapoorSiddhesh D Patil
Jun 28, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Abderrahim AissaouiAndrew D Miller
Mar 2, 2010·Bioorganic & Medicinal Chemistry Letters·Rajendra JoshiJörn Engelmann
May 11, 2005·Chembiochem : a European Journal of Chemical Biology·Matthieu SainlosPierre Lehn
Oct 6, 2006·Medicinal Research Reviews·Priya Prakash Karmali, Arabinda Chaudhuri
Feb 26, 2011·Journal of Peptide Science : an Official Publication of the European Peptide Society·Neha ShahHarendra S Parekh
Oct 10, 2006·Bioscience Reports·N Madhusudhana Rao, Vijaya Gopal
Jun 23, 2015·Biomacromolecules·Francesca ErcoleThomas P Davis
May 6, 2015·Molecular Pharmaceutics·Mathieu BerchelPaul-Alain Jaffrès
Dec 24, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Emile JubeliMichael D Pungente
Oct 19, 2006·International Journal of Pharmaceutics·Bingqi ZhangKangde Yao
Sep 30, 2016·Macromolecular Bioscience·Yanping SunPingtian Ding
Dec 5, 2009·New Journal of Chemistry = Nouveau Journal De Chimie·Meredith A MintzerEric E Simanek
Aug 23, 2018·Drug Delivery and Translational Research·Jasmin MonparaPradeep Vavia
Oct 24, 2009·Bioconjugate Chemistry·Tony Le GallJean-Luc Décout
Jul 31, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·Sabine CastanoBernard Desbat
Dec 5, 2008·Chemical Reviews·Meredith A Mintzer, Eric E Simanek
Feb 4, 2005·Journal of Medicinal Chemistry·Joyeeta Sen, Arabinda Chaudhuri

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.